ghk-cu topical vs injection Before and After Pictures – Neurogan Health Doctor Explains GHK-Cu the Glow

Do not take phentermine with MAO inhibitors, amphetamines, decongestants containing ephedrine or pseudoephedrine, or other weight-loss pills

Relative Contraindications Active or recent malignancy Pregnancy or breastfeeding (no safety data) Active systemic infection Uncontrolled autoimmune disease in acute flare Concurrent use of anticoagulants without physician oversight Regulatory Status and Where to Source BPC-157 FDA Status (as of 2025) BPC-157 is not FDA-approved for any human therapeutic indication

Protocol, Administration and Cost MIC is given intramuscularly, typically into the deltoid or gluteal muscle, most commonly weekly, sometimes twice weekly early in a programme

BPC-157 peptide therapy benefits include